In Development for Cystic Fibrosis
Rare Diseases
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
VP
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Vertex PharmaceuticalsVX-770
Vertex PharmaceuticalsVX-770
Clinical Trials (2)
Total enrollment: 48 patients across 2 trials
Study of VX-770 in Subjects With Moderate Hepatic Impairment and in Matched Healthy Subjects
Start: Sep 2010Est. completion: Dec 201024 patients
Phase 1Completed
Study of VX-770 on Desipramine
Start: Jun 2010Est. completion: Aug 201024 patients
Phase 1Completed
Related Jobs in Rare Diseases
Regional Gene Therapy Liaison - East Coast
Krystal Biotech
3h ago
Regional Gene Therapy Liaison - East Coast
Krystal Biotech
3h ago
Director, Clinical Development Operations Program Lead
Stoke Therapeutics
Bedford, Massachusetts, United States
3h ago
$236K - $260K/yr
Manager, Gene Therapy Operations (GTO)
Genetix Biotherapeutics
15h ago
From $130K/yr
Manager, Gene Therapy Operations (GTO)
Genetix Biotherapeutics
Somerville, Massachusetts, United States
15h ago
Ultra-Rare Disease Territory Account Specialist – Denver, CO
Novartis
Field Sales (USA)
Yesterday
$132K - $246K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space